ArticleOncotarget2018

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma.

Renier Heijkants et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.